The National Science Foundation has awarded a $250,000 grant to BioAesthetics Corp. to develop a new advanced wound-care product for treating bed sores

BioAesthetics Corporation announced that it doubled its $2.5M Series A goal, raising $5M to commercialize its NACgraft for breast cancer patients.

BioAesthetics Corporation announced a clinical study of its nipple reconstruction graft will be performed at Stanford Medicine beginning in 2021.

One New Orleans-based company, BioAesthetics, is transforming lives through advancements in biomaterials. The company recently announced it surpassed its $2.5 million Series A funding goal, with significant funding coming from the NO/LA Angel Network, The Pelican Fund, The Launch Place, FemHealth Ventures, New Orleans BioFund, IndieBio/SOSV, and other angel investors. BioAesthetics has developed a nipple-areolar […]

News: BioFund Portfolio Company BioAesthetics surpasses $2.5 million target raise BioAesthetics Surpasses Series A Goal, Further Advancing the Nipple-Areolar Complex Graft to Clinical Use BioAesthetics Corporation today announced that it has significantly surpassed its Series A funding goal of $2.5 million, further advancing its’ inaugural product — the nipple-areolar complex (NAC) graft, or NACgraftTM, for […]

Companies specializing in medical devices, digital health, and therapeutics were among the 59 companies that presented their four-minute business plan

BioAesthetics Corporation, a company transforming plastic and reconstructive surgeries through regenerative medicine, closed a financing round led by